Comparison of three test media for antimicrobial susceptibility testing of bifidobacteria using the Etest method

被引:16
作者
Matto, J. [1 ]
Suihko, M. -L. [1 ]
Saarela, M. [1 ]
机构
[1] VTT Tech Res Ctr Finland, FI-02044 Espoo, Finland
关键词
bifidobacterium; antimicrobial susceptibility; test medium; etest;
D O I
10.1016/j.ijantimicag.2006.02.010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The performance of three test media for antimicrobial susceptibility testing of bifidobacteria using the Etest was compared. All Bifidobacterium strains (n = 42) displayed good growth on try pticase-phytone-yeast extract agar JPY). Most strains showed good growth on lactic acid bacteria susceptibility test medium supplemented with cysteine (LSM + cys); Bifidobacterium bifidum showed moderate growth. Growth of seven strains was inadequate on Brucella blood agar (BRU) and an additional eight strains showed moderate growth. The minimum inhibitory concentrations (MICs) for tetracycline were highest on BRU and lowest on LSM + cys (agreement 57%), whereas the MICs for streptomycin were lowest on BRU and highest on TPY (agreement 40%). Occasional mismatches (agreement 71-91%) between the test media were also detected for the beta-lactam antibiotics. This study describes test medium-dependent variation of MICs and the applicability of LSM + cys for antimicrobial susceptibility testing of bifidobacteria. (c) 2006 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:42 / 48
页数:7
相关论文
共 26 条
[1]  
ALDRIDGE K E, 1987, Clinical Therapeutics, V10, P2
[2]  
Andremont A, 2003, ASM NEWS, V69, P601
[3]   Selective plating underestimates abundance and shows differential recovery of bifidobacterial species from human feces [J].
Apajalahti, JHA ;
Kettunen, A ;
Nurminen, PH ;
Jatila, H ;
Holben, WE .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2003, 69 (09) :5731-5735
[4]  
Charteris WP, 1998, LETT APPL MICROBIOL, V26, P333, DOI 10.1046/j.1472-765X.1998.00342.x
[5]   In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria [J].
Citron, DM ;
Merriam, CV ;
Tyrrell, KL ;
Warren, YA ;
Fernandez, H ;
Goldstein, EJC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) :2334-2338
[6]   EVALUATION OF THE E-TEST FOR SUSCEPTIBILITY TESTING OF ANAEROBIC-BACTERIA [J].
CITRON, DM ;
OSTOVARI, MI ;
KARLSSON, A ;
GOLDSTEIN, EJC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (10) :2197-2203
[7]   Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract [J].
Delgado, S ;
Flórez, AB ;
Mayo, B .
CURRENT MICROBIOLOGY, 2005, 50 (04) :202-207
[8]   Bacterial composition of commercial probiotic products as evaluated by PCR-DGGE analysis [J].
Fasoli, S ;
Marzotto, M ;
Rizzotti, L ;
Rossi, F ;
Dellaglio, F ;
Torriani, S .
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2003, 82 (01) :59-70
[9]   Bifidobacterium spp. and Lactobacillus acidophilus:: biological, biochemical, technological and therapeutical properties relevant for use as probiotics [J].
Gomes, AMP ;
Malcata, FX .
TRENDS IN FOOD SCIENCE & TECHNOLOGY, 1999, 10 (4-5) :139-157
[10]   Influence of the culture medium on antibiotic susceptibility testing of food-associated lactic acid bacteria with the agar overlay disc diffusion method [J].
Huys, G ;
D'Haene, K ;
Swings, J .
LETTERS IN APPLIED MICROBIOLOGY, 2002, 34 (06) :402-406